Frontiers in Pharmacology (Jun 2017)

Retraction: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn

  • Frontiers Editorial Office

DOI
https://doi.org/10.3389/fphar.2017.00426
Journal volume & issue
Vol. 8

Abstract

Read online

No abstracts available.